This suggests that IGF2BP2 serves as a reader for METTL14‐mediated m6A modification on ANKRD22, thereby enhancing the stability and translation efficiency of ANKRD22 mRNA and contributing to its upregulation in NPC tissues. Here, METTL14 is linked to nasopharyngeal carcinoma.